The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Matis Louis since 2016.
The trader's CIK number is 1650991.
At the time of the last reporting, Matis Louis was the SVP, Chief Development Officer of Pieris Pharmaceuticals, Inc.. (stock ticker symbol PIRS).
Also see all insider trading activities at Pieris Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | PIRS | 10,000 | $17,036 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-06-14 | PIRS | Buy | 7,915 | 1.71 | 13,534 |
| 2016-06-13 | PIRS | Buy | 2,085 | 1.68 | 3,502 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Matis Louis (SVP, Chief Development Officer of Pieris Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.